Close

Anti-gnrhr Antibody scFv (CAT#: MOM-18371-S(P))

DESCRIPTION CATALOG # SIZE PRICE
Recombinant Anti-Human gnrhr Antibody scFv Fragment MOM-18371-S(P) 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant Mouse Antibody scFv Fragment is directed against Human GNRHR, expressed in E. coli
  • Target
  • GNRHR
  • Type
  • scFv
  • Immunogen
  • Synthetic peptide: MANSASPEQNQHCSAINNSIPLMQGNLPY conjugated to BSA, corresponding to N terminal amino acids 1-29 of Human GnRHRMANSASPEQNQHCSAINNSIPLMQGNLPY
  • Species Reactivity
  • Human
  • Expression Host
  • E. coli
  • Applications
  • Suitable for use in ELISA, WB, Neut and most other immunological methods.
  • Specific Activity
  • Tested positive against native antigen.
  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Storage
  • 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.

BACKGROUND

  • Antigen Description
  • Gonadotropin Releasing Hormone (GnRH) is down-regulated by hCG and believed to be an autocrine factor that regulates the ovary. The Gonadotropin Releasing Hormone Receptor (GnRHR) is synthesized in the pituitary gland. Activin A has been shown to stimulate the synthesis of GnRHR, illustrating a possible mechanism for the modulation of gonadotropin responsiveness to GnRH.
  • Function
  • gonadotropin-releasing hormone receptor activity; growth hormone-releasing hormone receptor activity; receptor activity; signal transducer activity;
  • Synonyms
  • GNRHR; gonadotropin-releasing hormone receptor; GRHR; LHRHR; gnRH-R; gnRH receptor; luliberin receptor; type I GnRH receptor; leutinizing-releasing hormone receptor; leutinizing hormone releasing horomone receptor; gonadotropin-releasing hormone (type 1) receptor 1; LRHR; GNRHR1

Customer reviews and Q&As    

Related Products
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us